Join The Community

Summary

The product HGH underwent independent testing to verify its authenticity and purity. The sample, submitted by asteroidbiotech@proton.me, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed that the vial contained 3.64 mg / 10.92 IU of recombinant human growth hormone (rHGH) with a purity of 95.035%. No dimer or related proteins were detected.

The testing process began on 16 October 2024, with the sample received on 31 October 2024, and analysis completed on 4 November 2024. While the results indicate high purity, the lack of manufacturer and batch details highlights the importance of independent third-party testing for quality assurance. This report serves as an educational resource for harm reduction and informed decision-making.

Detailed Report

Product Overview

Testing Details

Testing Results

Verification Details

Evaluation of Manufacturer-Submitted Testing

This analysis highlights the quality of the tested HGH sample but warrants careful evaluation due to the lack of manufacturer and batch information. Without these details, consistency across different vials remains uncertain. While Janoshik Analytical provides reliable testing, independent validation across multiple samples is recommended to ensure product integrity.

Conclusion

The analysis confirms that the tested HGH sample contains 3.64 mg / 10.92 IU of rHGH with 95.035% purity, free of detectable dimers or related proteins. While these results suggest high product quality, further testing is necessary to determine batch consistency. This report is provided for educational purposes to support informed decision-making and harm reduction.

Disclaimer

This report is published for educational and harm reduction purposes. Testing submitted by manufacturer; however, it can still provide valuable insights when critically assessed alongside independent results. Readers are encouraged to use this information responsibly.